HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Structural and functional characterization of monomeric EphrinA1 binding site to EphA2 receptor.

Abstract
The EphA2 receptor is overexpressed in glioblastoma multiforme and has been to shown to contribute to cell transformation, tumor initiation, progression, and maintenance. EphrinA1 (eA1) is a preferred ligand for the receptor. Treatment with monomeric eA1, the form of eA1 found in the extracellular environment, causes receptor phosphorylation, internalization, and down-regulation with subsequent anti-tumor effects. Here, we investigated the structure-function relationship of a monomeric eA1 focusing on its G-H loop ((108)FQRFTPFTLGKEFKE(123)G), a highly conserved region among eAs that mediates binding to their receptors. Alanine substitution mutants of the G-H loop amino acids were transfected into U-251 MG glioblastoma multiforme cells, and functional activity of each mutant in conditioned media was assessed by EphA2 down-regulation, ERK and AKT activation and cellular response assays. Alanine substitutions at positions Pro-113 Thr-115, Gly-117, Glu-122, and also Gln-109 enhanced the EphA2 receptor down-regulation and decreased p-ERK and p-AKT. Substitution mutants of eA1 at positions Phe-108, Arg-110, Phe-111, Thr-112, Phe-114, Leu-116, Lys-118, Glu-119, and Phe-120 had a deleterious effect on EphA2 down-regulation when compared with eA1-WT. Mutants at positions Phe-108, Lys-18, Lys-121, Gly-123 retained similar properties to eA1-WT. Recombinant eA1-R110A, -T115A, -G117A, and -F120A have been found to exhibit the same characteristics as the ligands contained in the conditioned media mainly due to the differences in their binding to the receptor. Thus, we have identified variants of eA1 that possess either superagonistic or antagonistic properties. These new findings will be important in the understanding of the receptor/ligand interactions and in further design of anti-cancer therapies targeting the eA/EphA system.
AuthorsCarla M Lema Tomé, Enzo Palma, Sara Ferluga, W Todd Lowther, Roy Hantgan, Jill Wykosky, Waldemar Debinski
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 287 Issue 17 Pg. 14012-22 (Apr 20 2012) ISSN: 1083-351X [Electronic] United States
PMID22362770 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Ephrin-A1
  • Ligands
  • Protein Isoforms
  • Receptor, EphA2
  • Alanine
Topics
  • Alanine (chemistry)
  • Antineoplastic Agents (pharmacology)
  • Binding Sites
  • Cell Line, Tumor
  • Cell Membrane (metabolism)
  • Ephrin-A1 (chemistry)
  • Gene Expression Regulation
  • Humans
  • Ligands
  • Molecular Sequence Data
  • Mutagenesis
  • Protein Binding
  • Protein Conformation
  • Protein Isoforms
  • Protein Structure, Secondary
  • Receptor, EphA2 (chemistry)
  • Sequence Homology, Amino Acid
  • Surface Plasmon Resonance

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: